在孕期糖尿病中产期的多水:我们应该担心吗?
Mercedes Horcas-Martín1, Tania Luque-Patiño2, Claudia Usandizaga-Prat2
1Area of Obstetrics and Gynaecology, Department of Child and Mother Health and Radiology, School of Medicine, University of Cádiz, 11009 Cádiz, Spain.
Children (Basel, Switzerland)
|July 29, 2025
概括
妊娠期糖尿病中多水症增加了孕妇和产周并发症的风险. 通过测量羊水体积 (AFV) 的早期检测有助于控制胎儿过度生长并改善结果.
科学领域:
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 产科 产科 产科 产科 产科
- 周围生理学 周围生理学
背景情况:
- 异形多水症会使怀孕复杂化,增加孕产妇和产周风险.
- 孕期糖尿病 (GDM) 是一种常见的妊娠并发症.
- 需要进一步调查GDM和多水症之间的相互作用.
研究的目的:
- 调查多水症在被诊断为GDM的满期怀孕中的影响.
- 评估胚胎液体体积 (AFV) 测量与GDM怀孕中不良的孕产妇/孕产后结果之间的关联.
主要方法:
- 340名孕期GDM妇女 (37-40周) 的前性队列研究.
- 使用胚胎液指数 (AFI) 和单个最深的口袋 (SDP) 评估的胚胎液体体积.
- 分析了孕产妇和产周结局,并比较正常和多水症组,并对结局关联进行了后勤回归.
主要成果:
- 患有多水症的GDM怀孕显示,孕妇 (54.3%对27.5%) 和围产 (65.7%对46.5%) 的并发症风险显著更高.
- 增加的AFV与更高的胎儿过度生长率 (LGA: 21.4%,宏观体: 19.8%) 和较低的妊娠年龄 (SGA) 小胎儿 (6.3%) 相关.
- AFI和SDP都与新生儿体重和百分数相关;AFI与胎儿过度生长和SGA/IUGR风险降低有较强的关联.
结论:
- 在GDM怀孕中检测到多水症可以确定产科和围产并发症的高危子组.
- 增加的AFV (AFI≥18厘米或SDP≥6.5厘米) 与胎儿过度生长的风险有关.
- 强烈监测和优化分娩时间建议GDM病例与增加的AFV,以改善围产期的结果.
更多相关视频
相关概念视频
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes: Symptoms, Diagnosis, and Complications
694
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
694
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Teratogenicity
2.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K
Glucose Transporters
24.1K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
24.1K


